Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
Drug Discovery: Overview01:26

Drug Discovery: Overview

12.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.2K
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model01:29

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

34
Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
34
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

23
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
23
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

27
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
27
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

2.3K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GluD1 is localized at cholinergic synapses and is an acetylcholine receptor.

Molecular psychiatry·2026
Same author

A Molecular Playground for Spin-State Ice and Coupled Electron-Spin Dynamics.

Journal of the American Chemical Society·2026
Same author

Three-dimensional printing of multilayer stretchable electronics with inclined interconnect accesses.

Nature communications·2026
Same author

Development and validation of a machine learning-based model for assessing coronary artery disease risk in postmenopausal women: a dual-center retrospective study.

Nan fang yi ke da xue xue bao = Journal of Southern Medical University·2026
Same author

Building a SHAP interpretable prediction model for stroke-associated pneumonia [stroke-associated pneumonia (SAP)] in patients with aneurysmal subarachnoid hemorrhage (aSAH).

Frontiers in neurology·2026
Same author

A Fine-Tuned Multimodal AI Chatbot for Dietary Health and Nutrition, Purrfessor: Development and Mixed Methods Evaluation.

JMIR AI·2026
Same journal

VideoPASTA: 7K Preference Pairs That Matter for Video-LLM Alignment.

Proceedings of the Conference on Empirical Methods in Natural Language Processing. Conference on Empirical Methods in Natural Language Processing·2026
Same journal

Synth-SBDH: A Synthetic Dataset of Social and Behavioral Determinants of Health for Clinical Text.

Proceedings of the Conference on Empirical Methods in Natural Language Processing. Conference on Empirical Methods in Natural Language Processing·2026
Same journal

X-CoT: Explainable Text-to-Video Retrieval via LLM-based Chain-of-Thought Reasoning.

Proceedings of the Conference on Empirical Methods in Natural Language Processing. Conference on Empirical Methods in Natural Language Processing·2026
Same journal

DischargeSim: A Simulation Benchmark for Educational Doctor-Patient Communication at Discharge.

Proceedings of the Conference on Empirical Methods in Natural Language Processing. Conference on Empirical Methods in Natural Language Processing·2026
Same journal

From Scores to Steps: Diagnosing and Improving LLM Performance in Evidence-Based Medical Calculations.

Proceedings of the Conference on Empirical Methods in Natural Language Processing. Conference on Empirical Methods in Natural Language Processing·2026
Same journal

BMRetriever: Tuning Large Language Models as Better Biomedical Text Retrievers.

Proceedings of the Conference on Empirical Methods in Natural Language Processing. Conference on Empirical Methods in Natural Language Processing·2026
See all related articles

Related Experiment Video

Updated: Feb 24, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.6K

Assay2Mol: Large Language Model-based Drug Design Using BioAssay Context.

Yifan Deng1,2, Spencer S Ericksen3, Anthony Gitter1,2,4

  • 1Department of Computer Sciences, University of Wisconsin-Madison.

Proceedings of the Conference on Empirical Methods in Natural Language Processing. Conference on Empirical Methods in Natural Language Processing
|February 23, 2026
PubMed
Summary
This summary is machine-generated.

Assay2Mol, a new workflow, unlocks biochemical screening data for drug discovery. It generates novel drug candidates by learning from existing assay information, outperforming other methods.

More Related Videos

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

1.7K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.6K

Related Experiment Videos

Last Updated: Feb 24, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.6K
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

1.7K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.6K

Area of Science:

  • Biochemistry
  • Computational drug discovery
  • Bioinformatics

Background:

  • Scientific databases contain vast quantitative and text data.
  • Biochemical assays screen molecules against disease targets.
  • Unstructured text in assays holds valuable drug discovery information.
  • This information is largely untapped due to its format.

Purpose of the Study:

  • To present Assay2Mol, a large language model-based workflow.
  • To leverage existing biochemical screening assays for early-stage drug discovery.
  • To unlock the potential of unstructured assay data.

Main Methods:

  • Assay2Mol utilizes a large language model.
  • It retrieves existing assay records for similar targets.
  • It generates candidate molecules using in-context learning from retrieved data.

Main Results:

  • Assay2Mol outperforms recent machine learning approaches.
  • It effectively generates candidate ligand molecules for target protein structures.
  • The workflow promotes the generation of more synthesizable molecules.

Conclusions:

  • Assay2Mol capitalizes on existing biochemical screening assays.
  • It offers a novel approach for early-stage drug discovery.
  • The method enhances the generation of viable drug candidates.